Table of Contents
Conference Papers in Medicine
Volume 2013, Article ID 349796, 5 pages
http://dx.doi.org/10.1155/2013/349796
Conference Paper

Cardiovascular Biomarkers in ACS: State of the Art 2012

Department of Internal Medicine III, Cardiology, University Hospital Heidelberg, 69120 Heidelberg, Germany

Received 15 January 2013; Accepted 1 April 2013

Academic Editors: A. Bellou, C. Hamm, M. Möckel, and J. Searle

This Conference Paper is based on a presentation given by Evangelos Giannitsis at “Clinical Decisions in Acute Patients: ACS–POCT–Hypertension and Biomarkers” held from 19 October 2012 to 20 October 2012 in Berlin, Germany.

Copyright © 2013 Evangelos Giannitsis and Hugo A. Katus. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Mackay, G. Mensah, S. Mendis, and K. Greenlund, The Atlas of Heart Disease and Stroke, World Health Organization, Geneva, Switzerland, 2004.
  2. H. A. Katus, A. Remppis, F. J. Neumann et al., “Diagnostic efficiency of troponin T measurements in acute myocardial infarction,” Circulation, vol. 83, no. 3, pp. 902–912, 1991. View at Google Scholar · View at Scopus
  3. H. A. Katus, A. Remppis, T. Scheffold, K. W. Diederich, and W. Kuebler, “Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction,” American Journal of Cardiology, vol. 67, no. 16, pp. 1360–1367, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. “Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction,” Journal of the American College of Cardiology, vol. 36, no. 3, pp. 959–969, 2000.
  5. K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, B. R. Chaitman, and H. D. White, “Third universal definition of myocardial infarction,” Nature Reviews Cardiology, vol. 9, no. 11, pp. 620–633, 2012. View at Publisher · View at Google Scholar
  6. T. Reichlin, W. Hochholzer, S. Bassetti et al., “Early diagnosis of myocardial infarction with sensitive cardiac troponin assays,” The New England Journal of Medicine, vol. 361, no. 9, pp. 858–867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Keller, T. Zeller, D. Peetz et al., “Sensitive troponin I assay in early diagnosis of acute myocardial infarction,” The New England Journal of Medicine, vol. 361, no. 9, pp. 868–877, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. W. Hamm, J. P. Bassand, S. Agewall et al., “ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC),” European Heart Journal, vol. 32, no. 23, pp. 2999–3054, 2011. View at Google Scholar
  9. E. Giannitsis and H. A. Katus, “Pros and cons of high-sensitivity assays for cardiac troponin,” Nature Reviews. Cardiology, vol. 9, no. 11, pp. 616–618, 2012. View at Publisher · View at Google Scholar
  10. K. Thygesen, J. Mair, H. Katus et al., “Recommendations for the use of cardiac troponin measurement in acute cardiac care,” European Heart Journal, vol. 31, no. 18, pp. 2197–2204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A. S. Jaffe, and H. A. Katus, “Analytical validation of a high-sensitivity cardiac troponin T assay,” Clinical Chemistry, vol. 56, no. 2, pp. 254–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. K. Saenger, R. Beyrau, S. Braun et al., “Multicenter analytical evaluation of a high-sensitivity troponin T assay,” Clinica Chimica Acta, vol. 412, no. 9-10, pp. 748–754, 2011. View at Google Scholar
  13. E. Giannitsis, M. Becker, K. Kurz, G. Hess, D. Zdunek, and H. A. Katus, “High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission,” Clinical Chemistry, vol. 56, no. 4, pp. 642–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Thygesen, J. Mair, E. Giannitsis et al., “How to use high-sensitivity cardiac troponins in acute cardiac care,” European Heart Journal, vol. 33, no. 18, pp. 2252–2257, 2012. View at Publisher · View at Google Scholar
  15. K. Kurz, E. Giannitsis, M. Becker, G. Hess, D. Zdunek, and H. A. Katus, “Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome,” Clinical Research in Cardiology, vol. 100, no. 3, pp. 209–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Than, L. Cullen, S. Aldous et al., “2-hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial,” Journal of the American College of Cardiology, vol. 59, no. 23, pp. 2091–2098, 2012. View at Google Scholar
  17. T. Reichlin, C. Schindler, B. Drexler et al., “One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T,” Archives of Internal Medicine, vol. 172, no. 16, pp. 1211–1218, 2012. View at Publisher · View at Google Scholar
  18. L. K. Newby, “Myocardial infarction rule-out in the emergency department: are high-sensitivity troponins the answer?: comment on ‘One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T’,” Archives of Internal Medicine, vol. 172, no. 16, pp. 1218–1219, 2012. View at Google Scholar
  19. T. Keller, S. Tzikas, T. Zeller et al., “Copeptin improves early diagnosis of acute myocardial infarction,” Journal of the American College of Cardiology, vol. 55, no. 19, pp. 2096–2106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Reichlin, W. Hochholzer, C. Stelzig et al., “Incremental value of copeptin for rapid rule out of acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 1, pp. 60–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Giannitsis, T. Kehayova, M. Vafaie, and H. A. Katus, “Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction,” Clinical Chemistry, vol. 57, no. 10, pp. 1452–1455, 2011. View at Publisher · View at Google Scholar
  22. M. Mueller, M. Biener, M. Vafaie et al., “Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome,” Clinical Chemistry, vol. 58, no. 1, pp. 209–218, 2012. View at Google Scholar
  23. S. Agewall, E. Giannitsis, T. Jernberg, and H. Katus, “Troponin elevation in coronary vs. non-coronary disease,” European Heart Journal, vol. 32, no. 4, pp. 404–411, 2011. View at Google Scholar
  24. K. M. Eggers, L. Lind, H. Ahlström et al., “Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects,” European Heart Journal, vol. 29, no. 18, pp. 2252–2258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Korosoglou, S. Lehrke, D. Mueller et al., “Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque,” Heart, vol. 97, no. 10, pp. 823–831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Irfan, R. Twerenbold, M. Reiter et al., “Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain,” American Journal of Medicine, vol. 125, no. 5, pp. 491–498, 2012. View at Publisher · View at Google Scholar
  27. S. Celik, E. Giannitsis, K. C. Wollert et al., “Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy,” Clinical Research in Cardiology, vol. 100, pp. 1077–1085, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Filusch, E. Giannitsis, H. A. Katus, and F. J. Meyer, “High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension,” Clinical Science, vol. 119, no. 5, pp. 207–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. Pascual-Figal, T. Casas, J. Ordonez-Llanos et al., “Highly sensitive troponin T for risk stratification of acutely destabilized heart failure,” American Heart Journal, vol. 163, no. 6, pp. 1002–1010, 2012. View at Publisher · View at Google Scholar
  30. G. J. Blake and P. M. Ridker, “C-reactive protein and other inflammatory risk markers in acute coronary syndromes,” Journal of the American College of Cardiology, vol. 41, no. 4, supplement, pp. S37–S42, 2003. View at Google Scholar · View at Scopus
  31. S. Q. Khan, R. J. O'Brien, J. Struck et al., “Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study,” Journal of the American College of Cardiology, vol. 49, no. 14, pp. 1525–1532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. James, B. Lindahl, A. Siegbahn et al., “N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy,” Circulation, vol. 108, no. 3, pp. 275–281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Meune, C. Balmelli, R. Twerenbold et al., “Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin,” International Journal of Cardiology, 2012. View at Publisher · View at Google Scholar
  34. S. von Haehling, J. Papassotiriou, N. G. Morgenthaler et al., “Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease,” International Journal of Cardiology, vol. 162, no. 1, pp. 27–32, 2012. View at Publisher · View at Google Scholar
  35. B. Lindahl, P. Venge, and L. Wallentin, “Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group,” Journal of the American College of Cardiology, vol. 29, no. 1, pp. 43–48, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. D. A. Morrow, E. M. Antman, M. Tanasijevic et al., “Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy,” Journal of the American College of Cardiology, vol. 36, no. 6, pp. 1812–1817, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. D. A. Morrow, C. P. Cannon, N. Rifai et al., “Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial,” Journal of the American Medical Association, vol. 286, no. 19, pp. 2405–2412, 2001. View at Google Scholar · View at Scopus
  38. A. Kastrati, J. Mehilli, F. J. Neumann et al., “Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial,” Journal of the American Medical Association, vol. 295, no. 13, pp. 1531–1538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. S. R. Mehta, C. P. Cannon, K. A. A. Fox et al., “Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials,” Journal of the American Medical Association, vol. 293, no. 23, pp. 2908–2917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Wallentin, R. C. Becker, A. Budaj et al., “Ticagrelor versus clopidogrel in patients with acute coronary syndromes,” The New England Journal of Medicine, vol. 361, no. 11, pp. 1045–1057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Jernberg, B. Lindahl, A. Siegbahn et al., “N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease,” Journal of the American College of Cardiology, vol. 42, no. 11, pp. 1909–1916, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. D. A. Morrow, J. A. de Lemos, M. S. Sabatine et al., “Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18,” Journal of the American College of Cardiology, vol. 41, no. 8, pp. 1264–1272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. S. K. James, J. Lindbäck, J. Tilly et al., “Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy,” Journal of the American College of Cardiology, vol. 48, no. 6, pp. 1146–1154, 2006. View at Publisher · View at Google Scholar · View at Scopus